Serum concentrations of semaphorins in patients with chronic hepatitis C (CHC) and healthy controls. by Neven Papic (407314)

“…Serum concentration of SEMA5A decreases with fibrosis progression (<b>B</b>), while serum concentrations of SEMA3C (<b>C</b>) and SEMA6D (<b>D</b>) increase with fibrosis stage. …”

On the derivation of a spatially distributed aerosol climatology for its incorporation in a radiometric Landsat pre-processing framework by D. Frantz (772435)

Retinoic acid alleviates decrease of phospho-Bad and 14-3-3 interaction caused by MCAO damage. by Ju-Bin Kang (16021324)

“…Densitometric analysis is represented as a ratio, proteins intensity to β-actin (B) or IgG (D) intensity. …”

JH regulates ovarian development: (A) The application of <i>HMGR</i>-<i>JHAMT</i> dsRNA results in a dramatic decrease of JH biosynthesis (n = 16). by Juan Huang (41654)

The pattern of a ventricular arrhythmia in this animal model. by Po-Cheng Chang (438891)

Serum Vitamin D Concentration ≥75 nmol/L Is Related to Decreased Cardiometabolic and Inflammatory Biomarkers, Metabolic Syndrome, and Diabetes; and Increased Cardiorespiratory Fitn... by Ganji, Vijay

Get full text
Get full text

Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial by José Tarcisio G. Carvalho (4217248)

Subjects:

SEM-EDS results of different salt-containing specimens without freeze-thaw curing: (a) S1; (b) S5; (c) S9; (d) S13. by Liang Xiong (1426411)

Change of SMAD4 after TGFβ inhibitor /activator treatment. by Jingping Ge (636557)

“…Protein levels were measured by Western blot analysis. A) Decrease of total p-SMAD2 after SB431542 treatment in all iPSCs, and increase of p-SMAD2 in both DBA iPSCs after the TGFβ1 treatment. …”

Nimodipine does not affect Aβ levels in cortex or hippocampus. by Katherine R. Sadleir (12035242)

IODVA1 inhibits lamellipodia and circular dorsal ruffle (CDR) formation in MDA-MB-231 cells and decreases Rac activation. by Anjelika Gasilina (8566296)

Non-Steady-State Fickian Diffusion Models Decrease the Estimated Gel Layer Diffusion Coefficient Uncertainty for Diffusive Gradients in Thin-Films Passive Samplers by Samuel D. Hodges (16412358)

“…A finite difference model (FDM) developed based on Fick’s second law with non-steady-state (N-SS) flux decreased uncertainty in <i>D</i>_Gel tenfold. …”

FEA results meshes for 5N force. by Nathan L. Wright (18389458)

Immunotherapy using PS-liposomes filled with insulin peptides decreases T1D incidence. by Irma Pujol-Autonell (412903)

TMEM16A knockdown induced a decrease in proliferation of SW620 cells. by Yujie Sui (549090)

Data from all independent trials of adhesion assay (in Fig 5B–5C) and CP activity assay (in Fig 5D–5F). by Han Jiang (195350)

Administration of BL-7010 (Polymers A and B) at a gluten: BL-7010 ratio of 1∶3 decreased gluten-associated histological pathology in the small intestine of sensitized mice. by Justin L. McCarville (432593)

POS treatment decreases ROS level and upregulates mitochondrial biogenesis in ARPE-19 cells through PGC-1α. by Murilo F. Roggia (755997)

“…<b>(C)</b> Knockdown Efficacy of PGC-1α siRNA was confirmed by mRNA levels measured by RT-PCR (Mean ± SEM, n = 6 per group, two-tailed Student’s <i>t-</i>test, ****<i>P</i> < 0.0001) and protein levels by western blot analysis (mean ± SEM, n = 3 per group, two-tailed Student’s <i>t-</i>test, **<i>P</i> < 0.01). <b>(D)</b> POS treatment decreased ROS level in cells transfected with control siRNA, but rather increased in those transfected with PGC-1α siRNA. …”

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

Hepatic and intestinal MTP expression following MTP ASO treatment. by Stephanie M. Marshall (223125)